Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) previous close was $4.41 while the outstanding shares total 4.89M. VRPX’s shares traded higher over the last trading session, gaining 16.55% on 05/26/21. The shares fell to a low of $4.2649 before closing at $5.14. Intraday shares traded counted 0.66 million, which was -321.54% lower than its 30-day average trading volume of 157.66K. The stock’s Relative Strength Index (RSI) is 68.25, with weekly volatility at 11.22% and ATR at 0.32. The VRPX stock’s 52-week price range has touched low of $3.79 and a $8.24 high.
Investors have identified the Biotechnology company Virpax Pharmaceuticals Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $25.13 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Virpax Pharmaceuticals Inc. (VRPX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 13.22 million total, with 2.64 million as their total liabilities.
Is the stock of VRPX attractive?
In related news, Director, Jambulingam Thani bought 100 shares of the company’s stock in a transaction that recorded on Feb 17. The purchase was performed at an average price of 7.16, for a total value of 716. In the last 6 months, insiders have changed their ownership in shares of company stock by 58.50%.